- Volume is elevated versus the 13-week average, confirming attention.
PHO
OSL
Week ended 07 Aug 2026
Weekly Investor Report
Photocure ASA · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
51.50 NOK
-2.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -18.4% below the Trend Line and sits at 15.6% of its 52-week range. The latest completed week returned -2.5%, after a -12.7% four-week move. The latest news-sentiment score is 58/100.
Setup score
33
out of 100
Latest Close
51.50 NOK
7 Aug 2026
1W Return
-2.5%
latest completed week
4W Return
-12.7%
short-term follow-through
12W Return
-17.9%
quarterly tape
Trend Breadth
59.6%
31 of 52 weeks active
Volume Ratio
4.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.5%
Latest completed week; four-week move -12.7%.
Indicator stack
33/28
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
58/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -18.4% below the Trend Line and sits at 15.6% of its 52-week range. The latest completed week returned -2.5%, after a -12.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 4.2x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0712-week average 0.31
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -12.7% over four weeks, -17.9% over 12 weeks, and -15.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year31
Trend breadth59.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.16Latest activity-pressure read.
Pressure change-14.3%Four-week change in activity pressure.
Leadership-26.74Latest relative-leadership reading.
RS change-88.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment58/100
Weighted news tone is neutral across 5 relevant articles.
2 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-35.5%Distance below the 52-week high.
13-week volatility3.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+26.2%Week of 17 Apr.
Worst week-10.2%Week of 24 Apr.
Latest week-2.5%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains6
Flat weeks0
Modest losses9
Sharp losses7
Recent vol3.2%13-week weekly-return volatility.
Base vol6.0%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -4.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorNO Healthcare
4-week rank24 / 24
Group average4.3%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD37.5%positive activity pressure
RS29.2%positive relative leadership
Four-week leaders
IndustryNO Drug Manufacturers - Specialty & Generic
4-week rank2 / 2
Group average-7.3%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape35/100
Trend, activity pressure, participation, and risk combine to a 35/100 tape read.
Indicator analysis10/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.07; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment58/100Weighted news tone is neutral across 5 relevant articles.
Photocure (OB:PHO) Stock Faces Margin Squeeze Despite Revenue Growth Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 51.50 NOK | -2.5% | 63.12 NOK | 58.02 NOK | -1.16 | -26.74 | 751.5K | Off |
| 31 Jul 2026 | 52.80 NOK | -5.9% | 63.94 NOK | 57.97 NOK | -1.10 | -25.10 | 330.9K | Off |
| 24 Jul 2026 | 56.10 NOK | -2.8% | 64.58 NOK | 57.93 NOK | -1.10 | -20.58 | 175.9K | Off |
| 17 Jul 2026 | 57.70 NOK | -2.2% | 64.99 NOK | 57.87 NOK | -0.99 | -16.67 | 129.8K | Off |
| 10 Jul 2026 | 59.00 NOK | 0.3% | 65.35 NOK | 57.81 NOK | -1.02 | -14.17 | 101.5K | Off |
| 3 Jul 2026 | 58.80 NOK | -3.3% | 65.62 NOK | 57.74 NOK | -1.11 | -15.15 | 28.8K | Off |
| 26 Jun 2026 | 60.80 NOK | 1.3% | 65.87 NOK | 57.66 NOK | -1.09 | -10.51 | 13.4K | Off |
| 19 Jun 2026 | 60.00 NOK | 0.5% | 65.94 NOK | 57.57 NOK | -1.00 | -14.02 | 53.7K | Off |
| 12 Jun 2026 | 59.70 NOK | 1.4% | 65.88 NOK | 57.50 NOK | -0.78 | -16.37 | 50.5K | Off |
| 5 Jun 2026 | 58.90 NOK | -5.0% | 65.83 NOK | 57.44 NOK | -0.64 | -17.91 | 146.8K | Off |
| 29 May 2026 | 62.00 NOK | -6.2% | 65.78 NOK | 57.38 NOK | -0.49 | -13.58 | 155.3K | Off |
| 22 May 2026 | 66.10 NOK | 5.4% | 65.65 NOK | 57.31 NOK | -0.46 | -9.87 | 217.7K | Off |
| 15 May 2026 | 62.70 NOK | -2.2% | 65.14 NOK | 57.21 NOK | -0.39 | -13.44 | 165.2K | On |
| 8 May 2026 | 64.10 NOK | -2.6% | 64.81 NOK | 57.16 NOK | -0.14 | -9.41 | 293.0K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.